Global Clinical Trial Outsourcings Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Clinical Trial Outsourcings market report explains the definition, types, applications, major countries, and major players of the Clinical Trial Outsourcings market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • PPD

    • Sofpromed

    • IQVIA

    • Syneos Health

    • Quanticate

    • Chiltern International Ltd

    • SGS life Science

    • Charles River Laboratories

    • ICON Plc

    • PAREXEL International Corporation

    • Covance

    • PRA Health Sciences

    By Type:

    • Regulatory Services

    • Clinical Data Manage- ment (CDM)

    • Medical Writing

    • Site Management

    • Pharmacovigilance(PV)

    • Risk-Based Monitoring

    • Bio Statistical Services

    • Protocol Development

    By End-User:

    • Pharmaceutical Companies

    • Biopharmaceutical Companies

    • Drug Discovery Companies

    • Medical Devices Companies

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Clinical Trial Outsourcings Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Clinical Trial Outsourcings Outlook to 2028- Original Forecasts

    • 2.2 Clinical Trial Outsourcings Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Clinical Trial Outsourcings Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Clinical Trial Outsourcings Market- Recent Developments

    • 6.1 Clinical Trial Outsourcings Market News and Developments

    • 6.2 Clinical Trial Outsourcings Market Deals Landscape

    7 Clinical Trial Outsourcings Raw Materials and Cost Structure Analysis

    • 7.1 Clinical Trial Outsourcings Key Raw Materials

    • 7.2 Clinical Trial Outsourcings Price Trend of Key Raw Materials

    • 7.3 Clinical Trial Outsourcings Key Suppliers of Raw Materials

    • 7.4 Clinical Trial Outsourcings Market Concentration Rate of Raw Materials

    • 7.5 Clinical Trial Outsourcings Cost Structure Analysis

      • 7.5.1 Clinical Trial Outsourcings Raw Materials Analysis

      • 7.5.2 Clinical Trial Outsourcings Labor Cost Analysis

      • 7.5.3 Clinical Trial Outsourcings Manufacturing Expenses Analysis

    8 Global Clinical Trial Outsourcings Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Clinical Trial Outsourcings Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Clinical Trial Outsourcings Export by Region (Top 10 Countries) (2017-2028)

    9 Global Clinical Trial Outsourcings Market Outlook by Types and Applications to 2022

    • 9.1 Global Clinical Trial Outsourcings Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Regulatory Services Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Clinical Data Manage- ment (CDM) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Medical Writing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Site Management Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Pharmacovigilance(PV) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Risk-Based Monitoring Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Bio Statistical Services Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Protocol Development Consumption and Growth Rate (2017-2022)

    • 9.2 Global Clinical Trial Outsourcings Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Drug Discovery Companies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Medical Devices Companies Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Clinical Trial Outsourcings Market Analysis and Outlook till 2022

    • 10.1 Global Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.2.2 Canada Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.2.3 Mexico Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.2 UK Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.3 Spain Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.4 Belgium Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.5 France Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.6 Italy Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.7 Denmark Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.8 Finland Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.9 Norway Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.10 Sweden Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.11 Poland Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.12 Russia Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.3.13 Turkey Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.2 Japan Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.3 India Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.4 South Korea Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.5 Pakistan Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.6 Bangladesh Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.7 Indonesia Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.8 Thailand Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.9 Singapore Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.10 Malaysia Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.11 Philippines Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.4.12 Vietnam Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.2 Colombia Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.3 Chile Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.4 Argentina Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.5 Venezuela Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.6 Peru Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.7 Puerto Rico Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.5.8 Ecuador Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.6.2 Kuwait Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.6.3 Oman Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.6.4 Qatar Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.7.2 South Africa Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.7.3 Egypt Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.7.4 Algeria Clinical Trial Outsourcings Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Clinical Trial Outsourcings Consumption (2017-2022)

      • 10.8.2 New Zealand Clinical Trial Outsourcings Consumption (2017-2022)

    11 Global Clinical Trial Outsourcings Competitive Analysis

    • 11.1 PPD

      • 11.1.1 PPD Company Details

      • 11.1.2 PPD Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 PPD Clinical Trial Outsourcings Main Business and Markets Served

      • 11.1.4 PPD Clinical Trial Outsourcings Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sofpromed

      • 11.2.1 Sofpromed Company Details

      • 11.2.2 Sofpromed Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sofpromed Clinical Trial Outsourcings Main Business and Markets Served

      • 11.2.4 Sofpromed Clinical Trial Outsourcings Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 IQVIA

      • 11.3.1 IQVIA Company Details

      • 11.3.2 IQVIA Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 IQVIA Clinical Trial Outsourcings Main Business and Markets Served

      • 11.3.4 IQVIA Clinical Trial Outsourcings Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Syneos Health

      • 11.4.1 Syneos Health Company Details

      • 11.4.2 Syneos Health Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Syneos Health Clinical Trial Outsourcings Main Business and Markets Served

      • 11.4.4 Syneos Health Clinical Trial Outsourcings Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Quanticate

      • 11.5.1 Quanticate Company Details

      • 11.5.2 Quanticate Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Quanticate Clinical Trial Outsourcings Main Business and Markets Served

      • 11.5.4 Quanticate Clinical Trial Outsourcings Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Chiltern International Ltd

      • 11.6.1 Chiltern International Ltd Company Details

      • 11.6.2 Chiltern International Ltd Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Chiltern International Ltd Clinical Trial Outsourcings Main Business and Markets Served

      • 11.6.4 Chiltern International Ltd Clinical Trial Outsourcings Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 SGS life Science

      • 11.7.1 SGS life Science Company Details

      • 11.7.2 SGS life Science Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 SGS life Science Clinical Trial Outsourcings Main Business and Markets Served

      • 11.7.4 SGS life Science Clinical Trial Outsourcings Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Charles River Laboratories

      • 11.8.1 Charles River Laboratories Company Details

      • 11.8.2 Charles River Laboratories Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Charles River Laboratories Clinical Trial Outsourcings Main Business and Markets Served

      • 11.8.4 Charles River Laboratories Clinical Trial Outsourcings Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 ICON Plc

      • 11.9.1 ICON Plc Company Details

      • 11.9.2 ICON Plc Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 ICON Plc Clinical Trial Outsourcings Main Business and Markets Served

      • 11.9.4 ICON Plc Clinical Trial Outsourcings Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 PAREXEL International Corporation

      • 11.10.1 PAREXEL International Corporation Company Details

      • 11.10.2 PAREXEL International Corporation Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 PAREXEL International Corporation Clinical Trial Outsourcings Main Business and Markets Served

      • 11.10.4 PAREXEL International Corporation Clinical Trial Outsourcings Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Covance

      • 11.11.1 Covance Company Details

      • 11.11.2 Covance Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Covance Clinical Trial Outsourcings Main Business and Markets Served

      • 11.11.4 Covance Clinical Trial Outsourcings Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 PRA Health Sciences

      • 11.12.1 PRA Health Sciences Company Details

      • 11.12.2 PRA Health Sciences Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 PRA Health Sciences Clinical Trial Outsourcings Main Business and Markets Served

      • 11.12.4 PRA Health Sciences Clinical Trial Outsourcings Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Clinical Trial Outsourcings Market Outlook by Types and Applications to 2028

    • 12.1 Global Clinical Trial Outsourcings Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Regulatory Services Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Clinical Data Manage- ment (CDM) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Medical Writing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Site Management Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Pharmacovigilance(PV) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Risk-Based Monitoring Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Bio Statistical Services Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Protocol Development Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Clinical Trial Outsourcings Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Drug Discovery Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Medical Devices Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Clinical Trial Outsourcings Market Analysis and Outlook to 2028

    • 13.1 Global Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.2.2 Canada Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.2 UK Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.3 Spain Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.5 France Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.6 Italy Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.8 Finland Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.9 Norway Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.11 Poland Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.12 Russia Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.2 Japan Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.3 India Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.3 Chile Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.6 Peru Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.6.3 Oman Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Clinical Trial Outsourcings Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Clinical Trial Outsourcings Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Clinical Trial Outsourcings

    • Figure of Clinical Trial Outsourcings Picture

    • Table Global Clinical Trial Outsourcings Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Clinical Trial Outsourcings Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Regulatory Services Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Data Manage- ment (CDM) Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Writing Consumption and Growth Rate (2017-2022)

    • Figure Global Site Management Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacovigilance(PV) Consumption and Growth Rate (2017-2022)

    • Figure Global Risk-Based Monitoring Consumption and Growth Rate (2017-2022)

    • Figure Global Bio Statistical Services Consumption and Growth Rate (2017-2022)

    • Figure Global Protocol Development Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Discovery Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Devices Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Table North America Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure United States Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Canada Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Mexico Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table Europe Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure Germany Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure UK Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Spain Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Belgium Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure France Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Italy Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Denmark Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Finland Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Norway Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Sweden Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Poland Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Russia Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Turkey Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table APAC Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure China Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Japan Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure India Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure South Korea Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Thailand Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Singapore Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Philippines Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table South America Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure Brazil Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Colombia Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Chile Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Argentina Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Peru Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table GCC Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure Bahrain Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Oman Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Qatar Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table Africa Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure Nigeria Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure South Africa Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Egypt Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure Algeria Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table Oceania Clinical Trial Outsourcings Consumption by Country (2017-2022)

    • Figure Australia Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Clinical Trial Outsourcings Consumption and Growth Rate (2017-2022)

    • Table PPD Company Details

    • Table PPD Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table PPD Clinical Trial Outsourcings Main Business and Markets Served

    • Table PPD Clinical Trial Outsourcings Product Portfolio

    • Table Sofpromed Company Details

    • Table Sofpromed Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sofpromed Clinical Trial Outsourcings Main Business and Markets Served

    • Table Sofpromed Clinical Trial Outsourcings Product Portfolio

    • Table IQVIA Company Details

    • Table IQVIA Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table IQVIA Clinical Trial Outsourcings Main Business and Markets Served

    • Table IQVIA Clinical Trial Outsourcings Product Portfolio

    • Table Syneos Health Company Details

    • Table Syneos Health Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table Syneos Health Clinical Trial Outsourcings Main Business and Markets Served

    • Table Syneos Health Clinical Trial Outsourcings Product Portfolio

    • Table Quanticate Company Details

    • Table Quanticate Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quanticate Clinical Trial Outsourcings Main Business and Markets Served

    • Table Quanticate Clinical Trial Outsourcings Product Portfolio

    • Table Chiltern International Ltd Company Details

    • Table Chiltern International Ltd Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiltern International Ltd Clinical Trial Outsourcings Main Business and Markets Served

    • Table Chiltern International Ltd Clinical Trial Outsourcings Product Portfolio

    • Table SGS life Science Company Details

    • Table SGS life Science Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table SGS life Science Clinical Trial Outsourcings Main Business and Markets Served

    • Table SGS life Science Clinical Trial Outsourcings Product Portfolio

    • Table Charles River Laboratories Company Details

    • Table Charles River Laboratories Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table Charles River Laboratories Clinical Trial Outsourcings Main Business and Markets Served

    • Table Charles River Laboratories Clinical Trial Outsourcings Product Portfolio

    • Table ICON Plc Company Details

    • Table ICON Plc Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICON Plc Clinical Trial Outsourcings Main Business and Markets Served

    • Table ICON Plc Clinical Trial Outsourcings Product Portfolio

    • Table PAREXEL International Corporation Company Details

    • Table PAREXEL International Corporation Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table PAREXEL International Corporation Clinical Trial Outsourcings Main Business and Markets Served

    • Table PAREXEL International Corporation Clinical Trial Outsourcings Product Portfolio

    • Table Covance Company Details

    • Table Covance Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covance Clinical Trial Outsourcings Main Business and Markets Served

    • Table Covance Clinical Trial Outsourcings Product Portfolio

    • Table PRA Health Sciences Company Details

    • Table PRA Health Sciences Clinical Trial Outsourcings Sales, Price, Value and Gross Profit (2017-2022)

    • Table PRA Health Sciences Clinical Trial Outsourcings Main Business and Markets Served

    • Table PRA Health Sciences Clinical Trial Outsourcings Product Portfolio

    • Figure Global Regulatory Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Data Manage- ment (CDM) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Writing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Site Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacovigilance(PV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Risk-Based Monitoring Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bio Statistical Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Protocol Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Discovery Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Devices Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Table North America Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure United States Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure Germany Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure China Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure Brazil Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Clinical Trial Outsourcings Consumption Forecast by Country (2022-2028)

    • Figure Australia Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Clinical Trial Outsourcings Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.